• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Valvular Stenosis (2697)
Event Date 07/30/2014
Event Type  Injury  
Event Description
A 21mm trifecta valve was implanted in the aortic position on (b)(6) 2011.The patient was hospitalized (b)(6) 2014 for the management of complete heart block complicated by an infective endocarditis on an aortic bioprosthesis.The patient was placed on a dual course of antibiotics.The initial echo performed (b)(6) 2014 showed a degenerated, calcified valve with a mean gradient of 70mm hg with no signs of visible vegetation.Following an episode of torsade de pointe and repeated episodes of nsvt, the patient received an implantable defibrillator on (b)(6) 2014.The patient was transferred to a skilled facility for further rehabilitation.On (b)(6), the patient was readmitted to the cardiac unit for consideration of a replacement avr.A repeat tte revealed a compromised valve associated with severe stenosis and mild paravalvular leak (pvl) suspected to have been the result of a small rupture of a suture.On a subsequent ct scan the valve was considered normal without evidence of pvl.The final decision was due to multiple co-morbidities (alcoholic dilated cardiomyopathy, ulcerated oesophageal variaces, chronic alcoholism, cirrahosis child b9) a redo valve procedure is contraindicated.
 
Manufacturer Narrative
(b)(4).The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The results of the investigation are inconclusive since the device was not returned for analysis.Our investigation was limited to the review of the device history record, which showed that each manufacturing and inspection operation was performed and indicated complete in accordance with sjm specifications and procedures.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Manufacturer Narrative
(b)(4).
 
Event Description
Per report, the patient was diagnosed with recurrent endocarditis on (b)(6) 2015.On (b)(6) 2015, the 21mm trifecta valve was explanted and replaced with a second trifecta valve (size unknown).(clinical study patient id: (b)(6)).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer (Section G)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key4838638
MDR Text Key5945650
Report Number3007113487-2015-00026
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,company representati
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/19/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date03/28/2013
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot Number3368840
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/19/2015
Initial Date FDA Received06/11/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received10/17/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/30/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age53 YR
Patient Weight80
-
-